Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Long-Term Treatment with Rosiglitazone Delays Hematopoietic Recovery in Response to Stress

Wenyi Lu, Kaiyan Liu, Weimin Wang, Shujuan Wang, Yonghuai Feng

Blood (2015) 126 (23): 4769.

https://doi.org/10.1182/blood.V126.23.4769.4769

Published: 2015

Journal Articles

All-Trans Retinoic Acid and Interferon-Alpha Increase CD38 Expression on Adult T-Cell Leukemia Cells and Sensitize Them to T Cells Bearing Anti-CD38 Chimeric Antigen Receptors

Keichiro Mihara, MD PhD, Tetsumi Yoshida, MD, Seiko Ishida, MD PhD, Yoshifumi Takei, MD PhD, Akira Kitanaka, MD PhD, Kazuya Shimoda, MD PhD, Kazuhiro Morishita, MD PhD, Yoshihiro Takihara, MD PhD, Tatsuo Ichinohe, MD

Blood (2015) 126 (23): 591.

https://doi.org/10.1182/blood.V126.23.591.591

Published: 2015

Journal Articles

PPAR-γ Agonists Induce Growth Arrest of Kit/AML1-ETO Leukemia Cells Acting on Diverse Pathways

Valter Agosti, MD PhD, Daniela Talarico, Agostina Urzino, Raghavendra Vasudeva Murthi, PhD, Aurora Anna Rita Nocera, PhD, Emilia Dora Giovannone

Blood (2014) 124 (21): 5211.

https://doi.org/10.1182/blood.V124.21.5211.5211

Published: 2014

Journal Articles

Troglitazone and Prochloroperazine Repositioned As An Anti-Leukemia Stem Cell Drug Combination Using Chemical Genomics-Based Prediction

Duane C Hassane, PhD, Jeanne P. De Leon, Cheryl Corbett, Randall M Rossi, MS, Wen Xie, MS, Craig T. Jordan, PhD, Monica L. Guzman, PhD

Blood (2011) 118 (21): 1885.

https://doi.org/10.1182/blood.V118.21.1885.1885

Published: 2011

Journal Articles

Regulation of dectin-1–mediated dendritic cell activation by peroxisome proliferator–activated receptor-gamma ligand troglitazone

Grethe Kock, Anita Bringmann, Stefanie Andrea Erika Held, Solveig Daecke, Annkristin Heine, Peter Brossart

Blood (2011) 117 (13): 3569–3574.

https://doi.org/10.1182/blood-2010-08-302224

Published: 2011

Journal Articles

ARNT/HIF-1β: An AML Biomarker?

Selena Joy Williams, PhD, Chunhong Gu, PhD, Joelle dela Paz, MSc, Rena Buckstein, MD, Richard A. Wells, MD, DPhil

Blood (2010) 116 (21): 2903.

https://doi.org/10.1182/blood.V116.21.2903.2903

Published: 2010

Journal Articles

Drug-Induced, NKG2D-Dependent Sensitization of ALL Cell Lines to NK Recognition.

Laura Spence, MD, Sophie Hambleton, MD, PhD, Venetia Bigley, MD, Sarah Pagan, Matthew Collin, MD, PhD

Blood (2009) 114 (22): 2024.

https://doi.org/10.1182/blood.V114.22.2024.2024

Published: 2009

Journal Articles

Peroxisome Proliferator-Activated Receptor (PPAR)-Gamma Agonists Inhibit Dectin-1 mediated Activation of Human Dendritic Cells (DC).

Grethe Kock, Anita Bringmann, Stefanie Held, Karin von Schwarzenberg, Peter Brossart, MD

Blood (2009) 114 (22): 1645.

https://doi.org/10.1182/blood.V114.22.1645.1645

Published: 2009

Journal Articles

ARNT Mediates Chemotherapy Resistance by Modulating the Response to Oxidative Stress in AML Cells.

Richard A. Wells, MD, DPhil, Chunhong Gu, PhD, Joelle dela Paz, MSc

Blood (2009) 114 (22): 2737.

https://doi.org/10.1182/blood.V114.22.2737.2737

Published: 2009

Journal Articles

Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-γ

Raju C. Reddy, Venkata R. Narala, Venkateshwar G. Keshamouni, Jami E. Milam, Michael W. Newstead, Theodore J. Standiford

Blood (2008) 112 (10): 4250–4258.

https://doi.org/10.1182/blood-2007-12-128967

Published: 2008

Journal Articles

Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARγ cross talk with NF-κB and C/EBPβ

Li Hua Wang, Xiao Yi Yang, Xiaohu Zhang, William L. Farrar

Blood (2007) 110 (13): 4373–4384.

https://doi.org/10.1182/blood-2006-07-038026

Published: 2007

Journal Articles

Peroxisome Proliferator-Activated Receptor gamma (PPARγ) Regulates CD36 Gene Expression in Megakaryocytic Cell Lines.

Michael A. Thornton, Mortimer Poncz, Victor Badejogbin

Blood (2006) 108 (11): 4200.

https://doi.org/10.1182/blood.V108.11.4200.4200

Published: 2006

Journal Articles

Myeloma Cell Proliferation Is Inhibitied by the Activation of Adenosine Monophosphate Activated Protein Kinase (AMPK).

Philipp Baumann, Sonja Mandl-Weber, Bertold Emmerich, Christian Straka, Daniel Franke, Ralf Schmidmaier

Blood (2006) 108 (11): 5045.

https://doi.org/10.1182/blood.V108.11.5045.5045

Published: 2006

Journal Articles

15-Deoxy-Δ 12,14 -prostaglandin J 2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-κB activity and down-regulation of antiapoptotic proteins

Roberto Piva, Patrizia Gianferretti, Alessandra Ciucci, Riccardo Taulli, Giuseppe Belardo, M. Gabriella Santoro

Blood (2005) 105 (4): 1750–1758.

https://doi.org/10.1182/blood-2004-04-1360

Published: 2005

Journal Articles

DHEA Can Inhibit the Proliferation of Myeloma Cells and the IL-6 Production of Bone Marrow Mononuclear Cells from the Myeloma Patients.

Ken-ichiro Otsuyama, Zi Ma, Shangqin Liu, Fu-Jun Li, Saeid Abroun, Xu Zheng, Yasuko Maki, Naohiro Tsuyama, Masanori Obata, MD, Hideaki Ishikawa, MD, Michio M. Kawano, MD

Blood (2004) 104 (11): 2458.

https://doi.org/10.1182/blood.V104.11.2458.2458

Published: 2004

Journal Articles

Pioglitazone Inhibits the Growth of Human Leukemic Cell Lines and Primary Leukemic Cells in Vitro.

Yoshihiro Hatta, MD, Minoru Saiki, MD, Yuko Enomoto, Shin Aizawa, MD, Umihiko Sawada, MD, Takashi Horie, MD

Blood (2004) 104 (11): 4493.

https://doi.org/10.1182/blood.V104.11.4493.4493

Published: 2004

Journal Articles

Induction of Apoptosis in Multiple Myeloma by Ligands of Peroxisome Proliferator-Activated Receptor γ (PPAR-γ).

Jan Eucker, MD, Katharina Baengeroth, Ivana Zavrski, MD, Holger Krebbel, Chuanbing Zang, PhD, Ulrike Heider, MD, Christian Jakob, MD, Elena Elstner, PhD, Kurt Possinger, MD, Orhan Sezer, MD

Blood (2004) 104 (11): 4848.

https://doi.org/10.1182/blood.V104.11.4848.4848

Published: 2004

Journal Articles

Troglitazone Exerts a Cell-Dependent Effect on the Extracellular Secretion of VEGF 165 Independently from the Rapamycin Sensitivity or the Level of eIF4E Expression in AML-Derived Cells.

Ellen Friday, PhD, Jonathan Glass, MD, Francesco Turturro, MD

Blood (2004) 104 (11): 4363.

https://doi.org/10.1182/blood.V104.11.4363.4363

Published: 2004

Journal Articles

PPAR-gamma Agonists Inhibit Toll-Like Receptor Mediated Activation of Dendritic Cells Via the MAP Kinase and NF-kB Pathways.

Valdete Mirakaj, MB, Silke Appel, PhD, Frank Grünebach, PhD, Markus M. Weck, MS, Volker L. Reichardt, MD, Peter Brossart, MD

Blood (2004) 104 (11): 3442.

https://doi.org/10.1182/blood.V104.11.3442.3442

Published: 2004

Journal Articles

Preferential Uptake of Gamma Tocopherol by Mast Cells. Does This Uptake Affect Mast Cell Cytokine Production?.

Omar S. Aljitawi, MD, Mathew Fitzgerald, Min Qui, Koyamangalath Krishnan, MD, William L. Stone, Guha Krishnaswamy, MD

Blood (2004) 104 (11): 3793.

https://doi.org/10.1182/blood.V104.11.3793.3793

Published: 2004

NARROW

Long-Term Treatment with Rosiglitazone Delays Hematopoietic Recovery in Response to Stress

All-Trans Retinoic Acid and Interferon-Alpha Increase CD38 Expression on Adult T-Cell Leukemia Cells and Sensitize Them to T Cells Bearing Anti-CD38 Chimeric Antigen Receptors

PPAR-γ Agonists Induce Growth Arrest of Kit/AML1-ETO Leukemia Cells Acting on Diverse Pathways

Troglitazone and Prochloroperazine Repositioned As An Anti-Leukemia Stem Cell Drug Combination Using Chemical Genomics-Based Prediction

Regulation of dectin-1–mediated dendritic cell activation by peroxisome proliferator–activated receptor-gamma ligand troglitazone

ARNT/HIF-1β: An AML Biomarker?

Drug-Induced, NKG2D-Dependent Sensitization of ALL Cell Lines to NK Recognition.

Peroxisome Proliferator-Activated Receptor (PPAR)-Gamma Agonists Inhibit Dectin-1 mediated Activation of Human Dendritic Cells (DC).

ARNT Mediates Chemotherapy Resistance by Modulating the Response to Oxidative Stress in AML Cells.

Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-γ

Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARγ cross talk with NF-κB and C/EBPβ

Peroxisome Proliferator-Activated Receptor gamma (PPARγ) Regulates CD36 Gene Expression in Megakaryocytic Cell Lines.

Myeloma Cell Proliferation Is Inhibitied by the Activation of Adenosine Monophosphate Activated Protein Kinase (AMPK).

15-Deoxy-Δ 12,14 -prostaglandin J 2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-κB activity and down-regulation of antiapoptotic proteins

DHEA Can Inhibit the Proliferation of Myeloma Cells and the IL-6 Production of Bone Marrow Mononuclear Cells from the Myeloma Patients.

Pioglitazone Inhibits the Growth of Human Leukemic Cell Lines and Primary Leukemic Cells in Vitro.

Induction of Apoptosis in Multiple Myeloma by Ligands of Peroxisome Proliferator-Activated Receptor γ (PPAR-γ).

Troglitazone Exerts a Cell-Dependent Effect on the Extracellular Secretion of VEGF 165 Independently from the Rapamycin Sensitivity or the Level of eIF4E Expression in AML-Derived Cells.

PPAR-gamma Agonists Inhibit Toll-Like Receptor Mediated Activation of Dendritic Cells Via the MAP Kinase and NF-kB Pathways.

Preferential Uptake of Gamma Tocopherol by Mast Cells. Does This Uptake Affect Mast Cell Cytokine Production?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only